Get all your news in one place.
100's of premium titles.
One app.
Start reading
Barchart
Barchart
Wajeeh Khan

As Trump Promotes CBD, Should You Buy, Sell, or Hold Canopy Growth Stock?

Canopy Growth (CGC) shares soared about 18% on Monday after President Donald Trump endorsed cannabidiol (CBD) as a potential breakthrough in senior healthcare. 

CBD could “revolutionize senior healthcare,” Trump wrote on Truth Social over the weekend, reigniting speculation that marijuana may be reclassified under his administration. 

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.